drugset / Trial / NCT00627016

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

NCT00627016 ↗

Phase 3 Completed 305 enrolled Takeda
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Dexlansoprazole once daily (QD) is effective in treating patients with night heartburn.

Timeline

Start
2008-03
Primary completion
2009-03
Completion
2009-03

Outcome

Met primary endpoint

paper Dexlansoprazole MR 30 mg (n=152) was superior to placebo (n=153) in median percentage of nights without heartburn (73.1 vs. 35.7%, respectively; P<0.001). PMID 21224838 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexlansoprazole Other / unclassified 30 mg Oral